At the Stony Brook Children’s Hospital ribbon-cutting ceremony are, left to right front row: New York State Assemblyman Michael Fitzpatrick; Kevin Law, President of the Long Island Association and Chair of the Stony Brook Council; Kenneth Kaushansky MD, Senior Vice President, Health Sciences, and Dean, Renaissance School of Medicine at Stony Brook University; New York State Senator Kenneth P. LaValle; SUNY Chancellor Kristina M. Johnson; Michael Bernstein, PhD, Interim President, Stony Brook University; David and Michele Knapp from the Knapp Swezey and Island Outreach Foundations; New York State Senator John Flanagan; Peg McGovern, MD, PhD, Knapp Professor of Pediatrics and Physician-in-Chief, Stony Brook Children’s Hospital; Brookhaven Town CouncilwomanValerie Cartwright; and Lisa Santeramo, Assistant Secretary for Intergovernmental Affairs, representing New York State Governor Andrew M. Cuomo.
The project is part of a larger $450 million expansion that also includes a cancer center on Stony Brook University’s East Campus, adjacent and connected to Stony Brook University Hospital.
During the speech, which lasted about an hour, Dr. Bernstein touched on several topics including important university initiatives, key strategic commitments, enrollment growth, Stony Brook Medicine’s future, financial woes and successes and challenges in the future.
“It’s easier to share information and sharing information leads to more consistency and higher quality care,” says Dr. Brian O’Hea, director of the Carol M. Baldwin Breast Care Center at Stony Brook.
Dr. Bernstein addressed the assembled University faculty, students and staff, elected representatives and local community members where he summarized the events and accomplishments of the previous year while looking forward to future milestones and initiatives.
On Oct. 17, Stony Brook University commemorated the latest advancement in medical care for children with the completion of the new Stony Brook Children’s Hospital.
A study that clarifies understanding of the molecular origins of age-related neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease has been published by a Stony Brook-led team.
Dr. Laura Hogan’s areas of expertise are leukemia, particularly acute lymphoblastic leukemia, and oncology survivorship. (Survivorship starts at the time of disease diagnosis and continues throughout the rest of the patient's life.) Her research interests include relapsed acute lymphoblastic leukemia and oncology survivorship.